2010
DOI: 10.1016/j.annemergmed.2009.12.002
|View full text |Cite
|
Sign up to set email alerts
|

Intramuscular Cobinamide Sulfite in a Rabbit Model of Sublethal Cyanide Toxicity

Abstract: Objective To determine the ability of an intramuscular cobinamide sulfite injection to rapidly reverse the physiologic effects of cyanide toxicity. Background Exposure to cyanide in fires and industrial exposures and intentional cyanide poisoning by terrorists leading to mass casualties is an ongoing threat. Current treatments for cyanide poisoning must be administered intravenously, and no rapid treatment methods are available for mass casualty cyanide exposures. Cobinamide is a cobalamin (vitamin B12) anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
74
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 60 publications
(74 citation statements)
references
References 33 publications
0
74
0
Order By: Relevance
“…These data indicate that CN2-Cbi may be a prototype for a novel type of sGC-regulating therapeutic agent. It is unlikely that physiological concentrations of circulating cobinamides (Ͻ30 pM) or B 12 vitamins (ϳ300 pM) (Hardlei and Nexo, 2009) have any effects on sGC func- Because of high affinity to cyano groups, cobinamides are used for cyanide detoxification (Broderick et al, 2006) and doses of 800 mg/kg are deemed safe for laboratory animals (Brenner et al, 2010). Previous studies reported that nitrosyl-cobinamide functions as an NO donor (Broderick et al, 2007), increasing vasodilation and vasodilator-stimulated phosphoproteinphosphorylation, presumably through NO-dependent activation of sGC.…”
Section: Discussionmentioning
confidence: 99%
“…These data indicate that CN2-Cbi may be a prototype for a novel type of sGC-regulating therapeutic agent. It is unlikely that physiological concentrations of circulating cobinamides (Ͻ30 pM) or B 12 vitamins (ϳ300 pM) (Hardlei and Nexo, 2009) have any effects on sGC func- Because of high affinity to cyano groups, cobinamides are used for cyanide detoxification (Broderick et al, 2006) and doses of 800 mg/kg are deemed safe for laboratory animals (Brenner et al, 2010). Previous studies reported that nitrosyl-cobinamide functions as an NO donor (Broderick et al, 2007), increasing vasodilation and vasodilator-stimulated phosphoproteinphosphorylation, presumably through NO-dependent activation of sGC.…”
Section: Discussionmentioning
confidence: 99%
“…[14] Cobinamide (Cbi, Figure 1b) is a cobalamin derivative lacking DMBI moiety. Recently this compound has attracted researchers' interests due to the high efficacy of its derivatives as cyanide antidotes (sulfitocobinamide) [15][16][17] and cyanide chemosensors (monocyanocobinamide). [18][19][20] Cbi application is also of interest in the study of both Co 3+ → Co 2+ and Co…”
Section: Introductionmentioning
confidence: 99%
“…It is difficult to perform it in the dark, and conditions such as shock or wearing personal protective equipment may warrant alternative routes to IV delivery. 8,9 Federal research agencies have also requested non-IV administration of chemical countermeasures, with particular emphasis on the intramuscular route. 10 Hydroxocobalamin cannot be administrated intramuscularly because of the large volume of fluid required for administration.…”
mentioning
confidence: 99%
“…[5][6][7] However, in a mass casualty incident or after a structure fire involving many victims, rapid administration by non-IV routes are needed. 8 IV administration requires skilled personnel and fatigable dexterity. It is difficult to perform it in the dark, and conditions such as shock or wearing personal protective equipment may warrant alternative routes to IV delivery.…”
mentioning
confidence: 99%